Suyash Prasad - Net Worth and Insider Trading
Suyash Prasad Net Worth
The estimated net worth of Suyash Prasad is at least $2 Million dollars as of 2024-04-23. Suyash Prasad is the CMO and Head of R&D of Taysha Gene Therapies Inc and owns about 530,589 shares of Taysha Gene Therapies Inc (TSHA) stock worth over $1 Million. Suyash Prasad is also the Senior VP & Chief Med Officer of Audentes Therapeutics Inc and owns about 18,236 shares of Audentes Therapeutics Inc (BOLD) stock worth over $1 Million. Details can be seen in Suyash Prasad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Suyash Prasad has not made any transactions after 2022-07-06 and currently still holds the listed stock(s).
Transaction Summary of Suyash Prasad
Suyash Prasad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Suyash Prasad owns 2 companies in total, including Taysha Gene Therapies Inc (TSHA) , and Audentes Therapeutics Inc (BOLD) .
Click here to see the complete history of Suyash Prasad’s form 4 insider trades.
Insider Ownership Summary of Suyash Prasad
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2022-07-06 | CMO and Head of R&D |
| BOLD | Audentes Therapeutics Inc | 2019-06-05 | Senior VP & Chief Med Officer |
Suyash Prasad Latest Holdings Summary
Suyash Prasad currently owns a total of 2 stocks. Among these stocks, Suyash Prasad owns 530,589 shares of Taysha Gene Therapies Inc (TSHA) as of July 6, 2022, with a value of $1 Million and a weighting of 55.06%. Suyash Prasad also owns 18,236 shares of Audentes Therapeutics Inc (BOLD) as of May 13, 2019, with a value of $1 Million and a weighting of 44.94%.
Latest Holdings of Suyash Prasad
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2022-07-06 | 530,589 | 2.53 | 1,339,737 |
| BOLD | Audentes Therapeutics Inc | 2019-05-13 | 18,236 | 59.97 | 1,093,613 |
Holding Weightings of Suyash Prasad
Suyash Prasad Form 4 Trading Tracker
According to the SEC Form 4 filings, Suyash Prasad has made a total of 2 transactions in Taysha Gene Therapies Inc (TSHA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Taysha Gene Therapies Inc is the sale of 12,861 shares on July 6, 2022, which brought Suyash Prasad around $47,586.
According to the SEC Form 4 filings, Suyash Prasad has made a total of 1 transactions in Audentes Therapeutics Inc (BOLD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Audentes Therapeutics Inc is the sale of 10,000 shares on May 13, 2019, which brought Suyash Prasad around $369,800.
Insider Trading History of Suyash Prasad
- 1
Suyash Prasad Trading Performance
Suyash Prasad Ownership Network
Ownership Network List of Suyash Prasad
Ownership Network Relation of Suyash Prasad
Suyash Prasad Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Suyash Prasad is the CMO and Head of R&D of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include director & 10 percent owner Paul B Manning , Chief Financial Officer Kamran Alam , and 10 percent owner Session R.a. Ii .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Suyash Prasad made no insider transaction in Taysha Gene Therapies Inc (TSHA). Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net purchase of 18,066,667 shares made by Paul B Manning , a net sale of 549,095 shares made by Session R.a. Ii , and a net purchase of 777,778 shares made by Stalfort John A Iii .
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 19,405,000 shares were bought by its insiders, resulting in a net purchase of 18,822,905 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Suyash Prasad Mailing Address
Above is the net worth, insider trading, and ownership report for Suyash Prasad. You might contact Suyash Prasad via mailing address: C/o Audentes Therapeutics, Inc., 101 Montgomery St., Suite 2650, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
